Ginsenoside Rd ameliorated colitis by inducing p62-driven mitophagy-mediated NLRP3 inflammasome inactivation and upregulating of AMPK/ULK1 signaling pathway in DSS-induced murine colitis model [59]. This evidence concerns the gene ULK1 and colitis.